FI830830A0 - Ny farmaceutisk komposition - Google Patents

Ny farmaceutisk komposition

Info

Publication number
FI830830A0
FI830830A0 FI830830A FI830830A FI830830A0 FI 830830 A0 FI830830 A0 FI 830830A0 FI 830830 A FI830830 A FI 830830A FI 830830 A FI830830 A FI 830830A FI 830830 A0 FI830830 A0 FI 830830A0
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
complex
emepronium
doxycycline
propranolol
Prior art date
Application number
FI830830A
Other languages
English (en)
Other versions
FI78615C (fi
FI78615B (fi
Inventor
Carl-Aage Bergwitz-Larsen
Rolf Gustav Lennart Oesterlund
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Publication of FI830830A0 publication Critical patent/FI830830A0/fi
Application granted granted Critical
Publication of FI78615B publication Critical patent/FI78615B/fi
Publication of FI78615C publication Critical patent/FI78615C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036Galactans; Derivatives thereof
    • C08B37/0042Carragenan or carragen, i.e. D-galactose and 3,6-anhydro-D-galactose, both partially sulfated, e.g. from red algae Chondrus crispus or Gigantia stellata; kappa-Carragenan; iota-Carragenan; lambda-Carragenan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI830830A 1982-03-12 1983-03-11 Foerfarande foer framstaellning av ett komplex av karragenan och anvaendningen av karragenan som komplexbildande medel foer emepron. FI78615C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8201556 1982-03-12
SE8201556 1982-03-12

Publications (3)

Publication Number Publication Date
FI830830A0 true FI830830A0 (fi) 1983-03-11
FI78615B FI78615B (fi) 1989-05-31
FI78615C FI78615C (fi) 1989-09-11

Family

ID=20346240

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830830A FI78615C (fi) 1982-03-12 1983-03-11 Foerfarande foer framstaellning av ett komplex av karragenan och anvaendningen av karragenan som komplexbildande medel foer emepron.

Country Status (10)

Country Link
US (2) US4536495A (fi)
EP (1) EP0091409B1 (fi)
AT (1) ATE17824T1 (fi)
DE (2) DE91409T1 (fi)
DK (1) DK171716B1 (fi)
FI (1) FI78615C (fi)
HK (1) HK54688A (fi)
NL (1) NL960011I1 (fi)
NO (2) NO159697C (fi)
SG (1) SG22388G (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
DE3686275T2 (de) * 1985-01-11 1993-03-18 Teijin Ltd Praeparate mit verzoegerter freisetzung.
US5538954A (en) * 1994-06-24 1996-07-23 A/S Dumex (Dumex Ltd.) Salts of tetracyclines
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
IT1297461B1 (it) * 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
US8367098B2 (en) 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
US7485319B2 (en) * 2003-07-25 2009-02-03 Warner Chilcott Company, Inc. Doxycycline metal complex in a solid dosage form
WO2005046651A1 (en) * 2003-11-12 2005-05-26 Ranbaxy Laboratories Limited Liquid filled capsules of doxycycline
US20060183719A1 (en) * 2005-01-21 2006-08-17 Devries Tina M Tetracycline metal complex in a solid dosage form
US8357117B2 (en) * 2008-08-06 2013-01-22 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
WO2012018341A1 (en) * 2010-08-05 2012-02-09 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
US20130116203A1 (en) * 2011-11-07 2013-05-09 Scott R. Rajski Isothiocynates and glucosinolate compounds and anti-tumor compositions containing same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2636E (fr) * 1903-10-28 1904-06-03 Auguste Honnorat Table distributrice de cartes postales illustrées
FR5227E (fr) * 1905-02-02 1906-02-05 Zeiss Carl Soc Enveloppe ou chassis pour pellicules photographiques
FR5227M (fi) * 1966-03-18 1967-08-14
US3984571A (en) * 1970-03-10 1976-10-05 E. R. Squibb & Sons, Inc. Hydrocolloid containing liquid carrier for a diagnostic or therapeutic agent
US4014335A (en) * 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
JPS5630912A (en) * 1979-08-22 1981-03-28 Kagaku Shiryo Kenkyusho:Kk Preparation of remedy for psittacosis of bird
DE3071847D1 (en) * 1980-09-22 1987-01-15 Air Maze Corp Liquid-gas separator
US4536995A (en) * 1984-06-22 1985-08-27 Frederick Russell A Corner panel assembly

Also Published As

Publication number Publication date
DK171716B1 (da) 1997-04-07
FI78615C (fi) 1989-09-11
DE91409T1 (de) 1984-02-16
EP0091409B1 (en) 1986-02-05
NO159697C (no) 1989-02-01
NO830862L (no) 1983-09-13
HK54688A (en) 1988-07-29
NO1996005I1 (no) 1996-04-10
NL960011I1 (nl) 1996-10-01
ATE17824T1 (de) 1986-02-15
NO159697B (no) 1988-10-24
DE3362050D1 (en) 1986-03-20
FI78615B (fi) 1989-05-31
EP0091409A1 (en) 1983-10-12
DK90383D0 (da) 1983-02-25
US4536495A (en) 1985-08-20
DK90383A (da) 1983-09-13
SG22388G (en) 1988-07-15
US4693997A (en) 1987-09-15

Similar Documents

Publication Publication Date Title
DK468379A (da) Praeparater med langvarig medikamentafgivelse
IL58759A0 (en) Purified proteins,their preparation and pharmaceutical compositions containing them
TR18803A (tr) 2'4-dikloro-4'-benzoiluereido-defenil eterleri,bunlarin hazirlanisina aitusul ve bunlarin ensektisidler olarak kullanilmalari
NL190237C (nl) Amino-ethers en geneesmiddel dat deze amino-ethers bevat.
NL193855B (nl) Naftaleenderivaten alsmede farmaceutische en cosmetische preparaten, die deze derivaten bevatten.
NL182775C (nl) Corticosteroide bevattende farmaceutische preparaten.
FI830830A0 (fi) Ny farmaceutisk komposition
BE849788A (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
GB2038812B (en) 1,2,4,5-tetra - alkyl - 4 - phenylpiperidines and pharmaceutical preparations thereof
IL46783A0 (en) New aromatic dicarboximides,their manufacture and pharmaceutical preparations containing them
IL48238A (en) N-(4-halobenzyl)-n-sec.alkyln'-phenylureas,their preparation and fungicidal compositions containing them
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
DE2960506D1 (en) Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them
PH9660A (en) 17alpha,21-oxygenated-11beta-hydroxy-3,20-dioxo-d-homo-pregnanes and the pharmaceutical preparations containing them
OA05038A (fr) O-phénylthiophényl-phosphorothiolate et -phosphorodithioate d'O,S-dialkyle, compositions pesticides les contenant et applications.
ES483662A1 (es) Un procedimiento para la produccion de una 2-aminoetil-1-fe-nilindolina
NL7511245A (nl) N,n'-digesubstitueerde naftaleenaceetamidinen en farmaceutische toepassing daarvan.
IT1206323B (it) Preparazioni farmaceutiche con azione citostatica.
SE7509123L (sv) 3-metylpyrazol-5-karboxylat, sett att framstella desamma och lekemedelpreparat innehallande desamma.
IT8020699A0 (it) Composizioni farmaceutiche adattivita' mucolitica, broncosecretolitica e antibroncospastica.
IT1194677B (it) Composizione farmaceutica ad attivita' antiflogistica,antipiretica e antalgica
DE2861571D1 (en) Amidines, their preparation and pharmaceutical compositions containing them.
PH17058A (en) Dea-steroids,pharmaceutical preparations containing the same and method of use thereof
NL7901761A (nl) N-(2-aminocycloheptyl)acylanidinen en derzelve farmaceutische preparaten.
AU250265B2 (en) 2, 2'alkylene bis-(5, 6-dialkylbenzimidazoles and their preparation

Legal Events

Date Code Title Description
TC Name/ company changed in patent

Owner name: PHARMACIA AB

PC Transfer of assignment of patent

Owner name: PHARMACIA AB

MA Patent expired

Owner name: PHARMACIA AB